GSK Investigational Site
Niles, Illinois 60714
0 studies enrolling now · 6 studies all time
What they study most
Lung Cancer, Non-Small Cell, Neoplasms, Neoplasms, Breast, Neoplasms, Prostate, Prostatic Hyperplasia, Schizophrenia
Studies at this site
- Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
- A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) — Running, not enrolling
- Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia — Completed
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels — Completed
- Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer — Completed